In this clip from The Call @ Hedgeye, Healthcare analyst Tom Tobin discusses the impact of the new Omicron Covid variant on the healthcare space and how that will react to recent vaccine efficacy.

“The biggest concern I have is with the waning vaccine efficacy,” explains Tobin. “The challenge here is that obviously people are scared, but the reality is that we have a couple of weeks to wait here until you really know something.”

“What we got in terms of vaccine coverage now versus even four months ago is radically different. Even with waning vaccine efficacy it is radically different in a good way. I think the only thing to do is look at the rate of hospitalizations versus Covid cases. You’re going to know what is happening.”

(This clip is a small taste of what our subscribers get each day on The Call @ Hedgeye. In a nutshell, The Call is our morning research call hosted by Hedgeye CEO Keith McCullough with our 40+ analyst research team. It helps small and large investors alike make better decisions via unique and investable stock/sector updates Click here to learn more.)

Click HERE to register for HedgEye On The Prize